LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BL-B01D1 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BL-B01D1 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find a safe dose, and second, to check how well that dose works and how the body handles it. About 570 p…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New targeted drug BL-M07D1 enters early human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called BL-M07D1 in people with advanced HER2-positive or low-expression breast cancer and other solid tumors that have not responded to standard treatments. The study has two parts: first, finding the safest dose, and then testing that…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Tiny study tracks cancer Drug's journey through the body
Knowledge-focused Recruiting nowThis early-stage study looks at how the experimental drug saruparib is absorbed, distributed, and eliminated in 8 people with advanced solid tumors. Participants will receive the drug by mouth and by vein, with samples taken to track the drug and its breakdown products. The goal …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC